Data last refreshed 1 hour ago

Intellia Therapeutics, Inc.NTLA

NASDAQ • Healthcare

—

$14.20

P/E

—

PEG

—

FCF Yield

—

Rev Growth YoY

-9.5% YoY

Gross Margin

85.4%

Health Score

—

D/E Ratio

0.14

Confidence

—

Business Snapshot

Business snapshot content not available.

Financial Health

Risk Assessment

Metric deep-dives

P/E Ratio→Debt-to-Equity→FCF Yield→Gross Margin→Quick Ratio→Revenue Growth→
Last updated 1 hours ago · Data sourced from FMP & Finnhub · Not financial advice